201 related articles for article (PubMed ID: 3297289)
1. Strategies for the management of recurrent and advanced urologic cancers. Quality of life.
Herr HW
Cancer; 1987 Aug; 60(3 Suppl):623-30. PubMed ID: 3297289
[TBL] [Abstract][Full Text] [Related]
2. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
3. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
4. [Radiation therapy in locally advanced and/or relapsed urological tumors].
Bortolus R
Urologia; 2013; 80(3):212-24. PubMed ID: 24526598
[TBL] [Abstract][Full Text] [Related]
5. Palliative radiation therapy of symptomatic recurrent bladder cancer.
Yi SK; Yoder M; Zaner K; Hirsch AE
Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350
[TBL] [Abstract][Full Text] [Related]
6. [Urologic tumors in old age].
Debruyne FM
Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):65-8. PubMed ID: 3715964
[TBL] [Abstract][Full Text] [Related]
7. The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
Yuan H; Mao X; Bai Y; Li H; Liu L; Pu C; Li J; Tang Y; Wei Q; Han P
J Chemother; 2015 Aug; 27(4):195-200. PubMed ID: 25968487
[TBL] [Abstract][Full Text] [Related]
8. Pediatric genitourinary tumors.
Fichtner J; Dairiki Shortliffe LM
Curr Opin Oncol; 1993 May; 5(3):530-7. PubMed ID: 8388257
[TBL] [Abstract][Full Text] [Related]
9. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
Tonyali S; Yazici S
Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
11. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
12. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
[TBL] [Abstract][Full Text] [Related]
13. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).
Audenet F; Yates DR; Cussenot O; Rouprêt M
Urol Oncol; 2013 May; 31(4):407-13. PubMed ID: 20884249
[TBL] [Abstract][Full Text] [Related]
14. Treatment of bone metastases in urologic malignancies.
Froehner M; Hölscher T; Hakenberg OW; Wirth MP
Urol Int; 2014; 93(3):249-56. PubMed ID: 25115989
[TBL] [Abstract][Full Text] [Related]
15. Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma.
Liu MA; Li JW; Runcie K
Curr Oncol Rep; 2024 May; 26(5):496-503. PubMed ID: 38602581
[TBL] [Abstract][Full Text] [Related]
16. [Therapy for systemic urothelial cancer recurrence].
Lehmann J; Stöckle M
Urologe A; 2005 Apr; 44(4):369-74. PubMed ID: 15754166
[TBL] [Abstract][Full Text] [Related]
17. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
[TBL] [Abstract][Full Text] [Related]
18. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
Fradet V; Mauermann J; Kassouf W; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Tanguay S; Chin J; So A; Lattouf JB; Bell D; Saad F; Sheyegan B; Drachenberg D; Cagiannos I; Lacombe L
Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978
[TBL] [Abstract][Full Text] [Related]
20. Formidable Scenarios in Urothelial and Variant Cancers of the Urinary Tract.
Aragon-Ching JB; Choudhury A; Margulis V; Yu EY
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():262-275. PubMed ID: 31099661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
